Delivery Order SPE2DR25D1053-SPE2DR26FT752
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Xhance 93 microgram nasal spray in 16-milliliter units. This non-set-aside, competitively awarded contract utilizes firm fixed pricing with a ceiling value of $3,180.19 and an ultimate completion date of August 14, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $7,662.60 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16ml) on November 3, 2025, with an ultimate completion date of November 4, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for Xhance 93 micrograms nasal spray (16 milliliters) with a ceiling value of $3,221.73. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of November 5, 2025, and performance at the vendor's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,724.52 to AmerisourceBergen Drug Corp for Xhance 93 mcg nasal spray (16mL) on November 7, 2025, with completion targeted for November 10, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $12,134.11 to supply Xhance 93 MCG nasal spray (16 mL units) with an ultimate completion date of September 18, 2025. This non-competitive delivery order utilizes firm fixed pricing and was awarded on September 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under a larger indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,615.59 to AmerisourceBergen Drug Corp for Xhance 93 microgram nasal spray (16 milliliters) on October 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 31, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency awarded a $4,547.56 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for Xhance 93 microgram nasal spray (16 milliliters). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 4, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a $5,049.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XHANCE 93 MCG nasal spray (16 mL) on November 5, 2025, with completion targeted for November 6, 2025. This competitive award, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a $1,212.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Xhance 93 mcg nasal spray (16 mL). This firm fixed-price delivery order, which must be completed by August 11, 2025, represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,260.72, is for the delivery of the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT752Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Xhance 93 microgram nasal spray in 16-milliliter units. This is a firm fixed-price contract with a ceiling value of $1,241.25 and an ultimate completion date of November 12, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling diverse medical procurement requirements, serving customers including the Defense Health Agency and U.S. Coast Guard across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/10/25 |